Skip to main content

Loss of mTORC1 signaling alters pancreatic α cell mass and impairs glucagon secretion.

Citation
Bozadjieva, N., et al. “Loss Of Mtorc1 Signaling Alters Pancreatic Α Cell Mass And Impairs Glucagon Secretion.”. The Journal Of Clinical Investigation, pp. 4379-4393.
Center University of Michigan Vanderbilt University
Multicenter
Multicenter
Author Nadejda Bozadjieva, Manuel Blandino-Rosano, Jennifer Chase, Xiao-Qing Dai, Kelsey Cummings, Jennifer Gimeno, Danielle Dean, Alvin C Powers, George K Gittes, Markus A Rüegg, Michael N Hall, Patrick E MacDonald, Ernesto Bernal-Mizrachi
Keywords diabetes, Endocrinology, Islet cells, Metabolism, signal transduction
Abstract

Glucagon plays a major role in the regulation of glucose homeostasis during fed and fasting states. However, the mechanisms responsible for the regulation of pancreatic α cell mass and function are not completely understood. In the current study, we identified mTOR complex 1 (mTORC1) as a major regulator of α cell mass and glucagon secretion. Using mice with tissue-specific deletion of the mTORC1 regulator Raptor in α cells (αRaptorKO), we showed that mTORC1 signaling is dispensable for α cell development, but essential for α cell maturation during the transition from a milk-based diet to a chow-based diet after weaning. Moreover, inhibition of mTORC1 signaling in αRaptorKO mice and in WT animals exposed to chronic rapamycin administration decreased glucagon content and glucagon secretion. In αRaptorKO mice, impaired glucagon secretion occurred in response to different secretagogues and was mediated by alterations in KATP channel subunit expression and activity. Additionally, our data identify the mTORC1/FoxA2 axis as a link between mTORC1 and transcriptional regulation of key genes responsible for α cell function. Thus, our results reveal a potential function of mTORC1 in nutrient-dependent regulation of glucagon secretion and identify a role for mTORC1 in controlling α cell-mass maintenance.

Year of Publication
2017
Journal
The Journal of clinical investigation
Volume
127
Issue
12
Number of Pages
4379-4393
Date Published
12/2017
ISSN Number
1558-8238
DOI
10.1172/JCI90004
Alternate Journal
J. Clin. Invest.
PMID
29106387
PMCID
PMC5707167
Download citation